Small molecule · Neurology
AR-122
CNS-penetrant small moleculePlaceholder
An early programme designing brain-penetrant molecules against a target implicated in neurodegeneration.
Development stage
- Discovery
- Lead optimisation
- Preclinical
- Clinical
Scientific rationale
- Designs are co-optimised for potency and predicted blood–brain-barrier permeability.